Showing results (611-620 of 756) with videos related to
Sort By:
Pageof 76
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Control of the autoimmune response by type 2 nitric oxide synthaseF D Shi, M Flodström, S H Kim, et al.Leukemia|September 27, 2003
Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapyH Guven, M Gilljam, B J Chambers, et al.Journal of the American Geriatrics Society|September 1, 2000
The impact of legislation on psychotropic drug use in nursing homes: a cross-national perspectiveC M Hughes, K L Lapane, V Mor, et al.Proceedings of the National Academy of Sciences of the United States of America|November 15, 1991
Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric miceP Höglund, C Ohlén, E Carbone, et al.The Journal of Clinical Endocrinology and Metabolism|August 1, 1996
Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study GroupO Törring, L Tallstedt, G Wallin, et al.Neuroscience Letters|November 8, 2001
On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cellsN Bogdanovic, L Bretillon, E G Lund, et al.Neurology|October 26, 1999
Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sampleN Andreasen, L Minthon, A Clarberg, et al.Journal of Neuroimmunology|August 3, 1999
Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis ratsL P Zou, S H Pelidou, N Abbas, et al.Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|June 1, 1996
Decreased inositol (1,4,5)-trisphosphate receptor levels in Alzheimer's disease cerebral cortex: selectivity of changes and possible correlation to pathological severityL S Haug, A C Ostvold, R F Cowburn, et al.Neuroscience Letters|February 28, 1994
Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish familyL Lannfelt, N Bogdanovic, H Appelgren, et al.Pageof 76